Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Autologous Serum 20% vs 50% for Severe Dry Eye
NCT03436576Phase 3Unknown
- Sponsor
- Pontificia Universidad Católica de Chile
- Start
- Sep 2018
- Primary completion
- Oct 2018
- Modality
- Biologic (Biologic)
- Countries
- 1
01
Overview
A Phase 3 trial of autologous serum tears in dry eye syndrome (DED), sponsored by Pontificia Universidad Católica de Chile. Status: unknown.
02
Drugs
autologous serum tears
03
Conditions
dry eye syndrome (DED)
Beyond the preview
Go deeper on NCT03436576.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03436576.